Paper2155804
Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors.
Bowen WD and 3 others. Eur J Pharmacol, 1990. Cited by 115 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors. Papers, record 2155804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2155804
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Haloperidol | Major topic |
| Receptors, Dopamine | Major topic |
| Receptors, Opioid | Major topic |
| Animals | |
| Brain | |
| In Vitro Techniques | |
| Male | |
| Motor Activity | |
| Parasympathetic Nervous System | |
| Pentazocine | |
| Phosphatidylinositols | |
| Piperidines | |
| Rats | |
| Rats, Inbred Strains | |
| Receptors, sigma |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DA-04988 | NIDA NIH HHS | United States | R01DA004988 | PubMed and NIH | NIH RePORTER |
| NS-26746 | NINDS NIH HHS | United States | R01NS026746 | PubMed and NIH | NIH RePORTER |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,974,892 | Haloperidol induces neuroprotection and enhances neuromuscular function in both murine and human models of spinal muscular atrophy. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/41974892 | PubMed |
| 40,672,668 | Sigma‑2 Receptor/Transmembrane Protein 97 in Pain Modulation: Tracing Historical Roots and Current Research Directions. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40672668 | PubMed |
| 40,242,588 | Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40242588 | PubMed |
| 36,821,072 | The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets. | J Physiol Biochem | 2023 | https://conductscience.org/library/papers/36821072 | PubMed |
| 36,780,706 | Synthesis and Pharmacological Characterization of a Difluorinated Analogue of Reduced Haloperidol as a Sigma-1 Receptor Ligand. | ACS Chem Neurosci | 2023 | https://conductscience.org/library/papers/36780706 | PubMed |
| 34,345,383 | Pro-oxidant and degenerative effects of haloperidol under inflammatory conditions in rat; the involvement of SIRT1 and NF-κB signaling pathways. | Vet Res Forum | 2021 | https://conductscience.org/library/papers/34345383 | PubMed |
| 34,046,607 | In vitro and in vivo sigma 1 receptor imaging studies in different disease states. | RSC Med Chem | 2021 | https://conductscience.org/library/papers/34046607 | PubMed |
| 23,284,812 | Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. | PLoS One | 2012 | https://conductscience.org/library/papers/23284812 | PubMed |
| 19,587,856 | Pharmacology and therapeutic potential of sigma(1) receptor ligands. | Curr Neuropharmacol | 2008 | https://conductscience.org/library/papers/19587856 | PubMed |
| 19,326,101 | Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors. | Psychopharmacology (Berl) | 2009 | https://conductscience.org/library/papers/19326101 | PubMed |
| 17,961,544 | An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones. | Eur J Pharmacol | 2008 | https://conductscience.org/library/papers/17961544 | PubMed |
| 17,919,467 | A prototypical Sigma-1 receptor antagonist protects against brain ischemia. | Brain Res | 2007 | https://conductscience.org/library/papers/17919467 | PubMed |
| 16,573,831 | Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. | BMC Neurosci | 2006 | https://conductscience.org/library/papers/16573831 | PubMed |
| 16,075,285 | Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. | Psychopharmacology (Berl) | 2005 | https://conductscience.org/library/papers/16075285 | PubMed |
| 15,197,533 | Sigma receptors: biology and therapeutic potential. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/15197533 | PubMed |
| 11,167,668 | Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11167668 | PubMed |
| 9,763,469 | Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. | J Neurosci | 1998 | https://conductscience.org/library/papers/9763469 | PubMed |
| 9,533,984 | The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9533984 | PubMed |
| 8,872,358 | Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. | Br J Pharmacol | 1996 | https://conductscience.org/library/papers/8872358 | PubMed |
| 8,373,754 | Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. | J Psychiatry Neurosci | 1993 | https://conductscience.org/library/papers/8373754 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2155804
GET https://conductscience.org/api/papers/v1/2155804/cited_by?page=2